Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
August 21, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for October 26, 2007 Subscribe to this News Feed      
 

For Pets with Cancer, Oncura Partners Initiate 'QOL ON CHEMO'

Providing quality of life for pets being treated for cancer with chemotherapy, medications like Cerenia™, improve quality of life.
When we treat and prevent these visible and concerning symptoms in a pet, the families feel chemotherapy medications are not adversely affecting their pet

Dallas, TX (PRWEB) October 26, 2007 -- Oncura Partners believe that much like in humans, pre-emptive care to manage side effects of cancer related therapies, is critical to the quality of life of pet patients. The limiting factor in many chemotherapy treatment plans is patient side effects - nausea, vomiting and decreased appetite.

In the United States pets are living longer healthier lives and many pets now receive treatments for cancer. In fact, 60% of dogs over the age of six will be treated for some form of cancer. For dogs over ten years of age 50% will die from cancer.

"When we treat and prevent these visible and concerning symptoms in a pet, the families feel chemotherapy medications are not adversely affecting their pet", according to Brian J Huber, DVM, ABVP and President of Oncura Partners. "This treatment step is critical to providing the opportunity to complete the care and enhance the patients' response to Chemotherapy. Pet families do not realize the full effects of chemotherapy, however, when their pet is comfortable and eating without nausea, the veterinarian is more successful in therapy recommendations and families are happier with their decision to pursue Chemotherapy for their pet. "QOL on Chemo" (quality of life on chemotherapy) for all pet patients is something that is supported by, Pfizer Animal Health makers of Cerenia™ a new once daily anti-emetic that has been proven to be very safe and effective for managing vomiting due to chemotherapy " continued Dr. Huber.

Oncura Partners has integrated Cerenia™ information into all of our treatment plans for our pet patients. Realizing the "dual mode of action" of this anti-emetic and the "once daily" medication creates significant advantages over other medications we currently use.

About Oncura Partners: Oncura Partners provides comprehensive cancer care for companion animals through our partnership with board-certified oncology professionals and the use of online tools and veterinary facilities, nationwide. We offer these resources to help improve your patients' quality of life using advanced techniques to treat cancer, while supporting the business of veterinary oncology. You can visit Oncura Partners at http://www.oncurapartners.com or phone 1-866-233-9100.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/RW1wdC1GYWx1LVN1bW0tTG92ZS1UaGlyLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
LORAN HICKTON
Oncrura Partners
360-910-2636
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright